المؤلفون: A Fernández González, C Aparicio Carreño, A Gándara Ande, A Fórneas Sangil, S Fuertes Camporro, J Fra Yañez

المصدر: Section 7: Post Congress additions.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::26e6b2656c1b05f9a1a1cc58ac92fb1b
https://doi.org/10.1136/ejhpharm-2022-eahp.393

المؤلفون: C Aparicio Carreño, A Gándara Ande, A Fórneas Sangil, B Fernández González, A Ayastuy Ruiz, R Pampín Sánchez, C Martínez-Múgica Barbosa, A Fernández González

المصدر: Section 7: Post Congress additions.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::09dcdcd6999942a4bf389368c330fc7d
https://doi.org/10.1136/ejhpharm-2022-eahp.420

المؤلفون: FJ Barbazán-Vázquez, B Fernández-González, R Pampín-Sánchez, T Sampedro-Gimeno, B Rodríguez-de-Castro, C Aparicio-Carreño

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(7)

مصطلحات موضوعية: Male, Lung Neoplasms, Immune checkpoint inhibitors, Squamous cell lung cancer, 03 medical and health sciences, 0302 clinical medicine, Immune system, Carcinoma, Non-Small-Cell Lung, Medicine, Humans, Pharmacology (medical), Antitumor immunity, biology, business.industry, Middle Aged, Long term response, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Carcinoma, Squamous Cell, Antibody, business, After treatment, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445534b9fd8b5226d0fc8b4ce96dcca6
https://pubmed.ncbi.nlm.nih.gov/32268838

المؤلفون: C Aparicio Carreño, C Durán Román, B Fernández González, Y Labeaga Beramendi, C Martinez-Mugica Barbosa, FJ Barbazán Vázquez, Bárbara Rodríguez, A Gándara Ande

المصدر: Section 2: Selection, Procurement and Distribution.

مصطلحات موضوعية: Drug, medicine.medical_specialty, Total cost, media_common.quotation_subject, Conflict of interest, Economic shortage, Product (business), Compounding, Acute care, medicine, Operations management, Business, Economic impact analysis, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::66d4abf07a22103a83f4fa4b62cd93cf
https://doi.org/10.1136/ejhpharm-2020-eahpconf.46

المؤلفون: C Aparicio-Carreño, R Pampín-Sánchez, B Fernández-González, FJ Barbazán-Vázquez, B Rodríguez-de-Castro, T Sampedro-Gimeno

المصدر: Journal of Oncology Pharmacy Practice

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Lung Neoplasms, business.industry, Adenocarcinoma of Lung, Discontinuation, Nivolumab, Text mining, Internal medicine, medicine, Humans, Pharmacology (medical), Letters to the Editor, business, Metastatic Lung Adenocarcinoma, Long term control

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe2159e3983ac6c237fd19c1de9296ce
https://doi.org/10.1177/10781552211004680

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

عنوان ترانسليتريتد: Dosificación de cefazolina prequirúrgica en pacientes obesos y no obesos. ¿Importa el peso?

المؤلفون: Rodríguez de Castro B; Belén Rodríguez de Castro, Servicio de Farmacia. Hospital Universitario Cabueñes. Los Prados, 395, 33394 Gijón (Asturias). Spain. b.rocas23@gmail.com., Martínez-Múgica Barbosa C, Pampín Sánchez R, Fernández González B, Barbazán Vázquez FJ, Aparicio Carreño C

المصدر: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2020 Jun; Vol. 33 (3), pp. 207-211. Date of Electronic Publication: 2020 Apr 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sociedad Española de Quimioterapia Country of Publication: Spain NLM ID: 9108821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1988-9518 (Electronic) Linking ISSN: 02143429 NLM ISO Abbreviation: Rev Esp Quimioter Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents/*administration & dosage , Antibiotic Prophylaxis/*methods , Cefazolin/*administration & dosage , Obesity/*metabolism , Surgical Wound Infection/*prevention & control, Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Body Mass Index ; Body Weight ; Cefazolin/therapeutic use ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Surgical Wound Infection/epidemiology